Literature DB >> 28654966

Randomized Trials of Chinese Herbal Medicine: A New Extension of the CONSORT Statement.

Klaus Linde1, Benno Brinkhaus1.   

Abstract

Entities:  

Year:  2017        PMID： 28654966     DOI： 10.7326/M17-1067

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

1.  Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial.

Authors:  Pan-Pan Tian; Jun Li; Jian Gao; Ying Li
Journal:  BMJ Open       Date:  2018-02-14       Impact factor: 2.692

2.  Effects of Danlou tablet for the treatment of stable angina pectoris: A study protocol of a randomized, double-blind, and placebo-controlled clinical trial.

Authors:  Guang Yang; Haoqiang He; Hongzheng Li; Zinuo Shen; Siyuan Zhou; Bingxu Lu; Jun Li; Qingyong He; Zhenpeng Zhang; Yongmei Liu; Jie Wang; Hengwen Chen
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.